Open AccessLong-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
Author(s) -
Aditi Gupta,
Lingam Gopal,
Parveen Sen,
Dhanashree Ratra,
Chetan Rao
Publication year - 2014
Publication title -
oman journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.306
H-Index - 16
eISSN - 0974-7842
pISSN - 0974-620X
DOI - 10.4103/0974-620x.137162
Subject(s) - medicine , choroidal neovascularization , ranibizumab , ophthalmology , fundus (uterus) , fluorescein angiography , choroid , visual acuity , surgery , bevacizumab , retina , chemotherapy , physics , optics
Though choroidal osteoma is a rare benign tumor, associated choroidal neovascularization (CNV) can be a cause of severe visual loss. A nine-year-old boy presented with one-month history of decreased vision in left eye. Upon a complete ophthalmologic examination, including fundus fluorescein angiography and optical coherence tomography, he was diagnosed with choroidal osteoma-related subfoveal CNV in the left eye. The CNV was associated with subretinal hemorrhage, subretinal fluid, and cystoid macular edema. Owing to the young age and subfoveal localization of the CNV, intravitreal ranibizumab injection was performed on this patient after a detailed discussion with the parents of its safety profile. No local or systemic complications were noted. No recurrence of CNV lesion was noted during 30 months of follow-up, and the vision was maintained. This report shows the favorable outcome of intravitreal injection of ranibizumab in choroidal osteoma-related CNV in a child.